secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001213900-26-051575
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix shareholders approve reverse stock split up to 1-for-10
-----------------------------------------------------------------

- Reverse split proposal approved with 1,301,918 for, 253,378 against, 1,393 abstentions.
- Board may implement one or more splits at ratios between 1:2 and 1:10 within one year, not exceeding 1:100 aggregate.
- Adjournment proposal also approved with 1,332,088 for, 223,071 against, 1,530 abstentions.
- Reverse split authorized without further stockholder approval; exact ratio to be set by the board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026051575/0001213900-26-051575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026051575/ea0288982-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-051575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer